The content on this site is intended for healthcare professionals only
Dr Naval Daver speaks to ecancer about the management of acute myeloid leukaemia (AML) patients during the COVID-19 pandemic.
He outlines his experience with treating AML patients during the coronavirus pandemic, and how treatment practices in his institution have changed as a result.
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Synthetic biology and precision medicine in blood and gynaecological cancers
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
OncoAlert Round Up for August 25th - 31st, 2023
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
Choosing wisely in multiple myeloma
